Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 860.05M | $ 15.52M | $ 0 | -1.8% |
3/31/2025 | $ 513.64M | $ 115.51M | $ 0 | -22.49% |
12/31/2024 | $ 457.26M | $ 170.13M | $ 0 | -37.21% |
9/30/2024 | $ 516.52M | $ 170.1M | $ 0 | -32.93% |
6/30/2024 | $ 630.03M | $ 271.06M | $ 0 | -43.02% |
3/31/2024 | $ 472.22M | $ 170.92M | $ 0 | -36.19% |
12/31/2023 | $ 488.97M | $ 116.93M | $ 0 | -23.91% |
9/30/2023 | $ 360.52M | $ 117.27M | $ 0 | -32.53% |
6/30/2023 | $ 642.3M | $ 2.31M | $ 0 | -0.36% |
3/31/2023 | $ 291.29M | $ 2.18M | $ 0 | -0.75% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for UROGEN PHARMA LTD is calculated as follows: (-1 * CF - Equity [ $ 16.82M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 549.9M ]
(=) Payout Yield [ -3.06% ]
Minimum
Jun 30, 2024
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |